Facial Aesthetics Line To Help Mentor Keep Up With Medicis/Inamed
This article was originally published in The Gray Sheet
Executive Summary
Mentor plans to compete with Inamed in the hyaluronic acid (HA) dermal filler market, following an expected PMA approval of its Hyalite non-animal stabilized HA filler early 2006
You may also be interested in...
BioForm Medical Does Not Expect Any Wrinkles In Upcoming Submission
BioForm Medical says it plans to submit a PMA for a new product to fill face wrinkles by the end of November
BioForm Medical Does Not Expect Any Wrinkles In Upcoming Submission
BioForm Medical says it plans to submit a PMA for a new product to fill face wrinkles by the end of November
Financings In Brief
Mentor: Santa Barbara, Calif. firm completes three-year syndicated credit agreement providing up to $200 mil. for pursuit of "licensing and acquisition opportunities" in markets where Mentor already competes, President & CEO Joshua Levine says. Bank of the West and Union Bank of California sponsored the agreement, which provides the option for a $50 mil. increase in the future. Separately, Mentor plans to launch its Hyalite non-animal stabilized hyaluronic acid, which it acquired through its 2003 purchase of A-life, in early 2006 (1"The Gray Sheet" May 30, 2005, p. 19). Hyalite will compete against Inamed's Hylaform avian-derived and Captique non-animal fillers, and Medicis' non-animal Restylane...